Inhibitory effects of zafirlukast on respiratory bursts of human neutrophils

Drugs under Experimental and Clinical Research

Volumn 28, Issue 4, 2002, Pages 133-145

  Braga, P C ^a   Dal Sasso, M ^a   Dal Negro, R ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b Bussolengo Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FORMYLMETHIONYLLEUCYLPHENYLALANINE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LUMINOL; PHORBOL 13 ACETATE 12 MYRISTATE; REACTIVE OXYGEN METABOLITE; ZAFIRLUKAST; ZYMOSAN;

ANTIOXIDANT ACTIVITY; ARTICLE; CANDIDA ALBICANS; CHEMOLUMINESCENCE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG STRUCTURE; HUMAN; HUMAN CELL; NEUTROPHIL; RESPIRATORY BURST;

CANDIDA ALBICANS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; NEUTROPHILS; PHAGOCYTOSIS; RESPIRATORY BURST; TOSYL COMPOUNDS; ZYMOSAN;

EID: 0036905471     PISSN: 03786501     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Boushey H.A., Holtzman M.J., Sheller J.R., Nadel J.A. Bronchial hyperreactivity. Am. Rev. Respir. Dis., 121, 389, 1980.
2. Juniper E.T., Frith P.A., Hargreave F.E. Airway responsiveness to histamine and methacholine: Relationship to minimum treatment to control symptoms of asthma. Thorax, 36, 575, 1980.
3. Postma D.S., Renkema T.E.J., Noordhoek J.A., Faber H., Sluiter H.J., Kauffman H. Association between nonspecific bronchial hyperreactivity and superoxide anion production by polymorphonuclear leukocytes in chronic air-flow obstruction. Am. Rev. Respir. Dis., 137, 57, 1988.
4. Chung K.F. Role of inflammation in the hyperreactivity of the airways in asthma Thorax, 41, 657, 1986.
5. Hargreave F.E., O'Byrne P.M., Rarusdale E.N. Mediators, airway responsiveness and asthma. J. Allergy Clin. Immunol., 76, 272, 1985.
6. Pauwels R. The relationship between airway inflammation and bronchial hyperresponsiveness. Clin. Exp. Allergy, 19, 395, 1989.
7. Larsen G.L., Wilson M.C., Clark R.A., Behrens B.L. The inflammatory reaction in the airways in an animal model of the late asthmatic response. Fed. Proc., 46, 105, 1987.
8. Martin L.D., Rochelle L.G., Fischer B.M., Krunkosky T.M., Adler K.B. Airway epithelium as an effector of inflammation: Molecular regulation of secondary mediators. Eur. Resp. J., 10, 2139, 1997.
9. Schmidt J., Kaufmann B., Lindstaedt R., Szelenyi I. Inhibition of chemiluminescence in granulocytes and alveolar macrophages by azelastine. Agents Actions, 31, 229, 1990
10. Rankin J.A. The contribution of alveolar macrophage to hyperreactive airway disease. J. Allergy Clin. Immunol., 83, 722, 1989.
11. Durham S.R., Carroll M., Walsh G.M., Kay A.B. Leukocyte activation in allergen-induced late-phase asthmatic reactions. N. Engl. J. Med., 311, 1398, 1984.
12. Wong K., Freund K. Inhibition of the n-formylmethionylleucyl-phenylalanine induced respiratory burst in human neutrophils by adrenergic agonists and prostaglandins of the E series. Can. J. Physiol. Pharmacol., 59, 915, 1981.
13. Fox R.B., Hoidal J.R., Brown D.M., Repine J.E. Pulmonary inflammation due to oxygen toxicity: Involvement of chemotactic factors from macrophages and polymorphonuclear leukocytes. Am. Rev. Respir. Dis., 123, 521, 1981.
14. Braga P.C., Mancini L., Guffanti E.E., Dal Sasso M., Sala M., Reggio S. Effects of nedocromil sodium on the oxidative burst of polymorphonuclear leukocytes. Comparison with salbutamol. Drugs Exptl. Clin. Res., 23, 33, 1997.
15. Kato M., Morikawa A., Kimura H., Shimizu T., Nakano M., Kuroume T. Effects of antiasthma drugs on superoxide anion generation from human polymorphonuclear leukocytes or hypoxanthine-xanthine oxidase system. Int. Arch. Allergy Appl. Immunol., 96, 128, 1991.
16. Henricks P.A.J., van Esch B., Nilkamp F.P. Beta-agonist can depress oxidative metabolism of alveolar macrophages. Agents Actions, 19, 353, 1986.
17. Neijens H.J., Raatgeep H.C., Degenhart H.J., Kerrebijn K.F. Responses of neutrophilic granulocytes in vitro of asthmatic and healthy subjects and the degree of inhibition by several drugs. Agents Actions, 26, 108, 1989.
18. Robinson P.D., Wakefield D., Breit S.N., Easter J.F., Penny R. Chemiluminescence response to pathogenic organisms. Normal human polymorphonuclear leukocytes. Infect. Immun., 43, 744, 1984.
19. Siegel J.P., Remington J.S. Effect of antimicrobial agents on chemiluminescence of human polymorphonuclear leukocytes in response to phagocytosis. J. Antimicrob. Chemother., 10, 505, 1982.
20. Briheim G., Dahlgren C. Influence of antibiotics on formylmethionyl-leucyl-phenylalanine-induced leukocyte chemiluminescence. Antimicrob. Agents Chemother., 31, 763, 1987.
21. Whitehead T.P., Thorpe G.H.G., Maxwell S.R.J. Enhanced chemiluminescence assay for antioxidant capacity in biological fluids. Anal. Chem. Acta. 266, 265, 1992
22. Robinson E.E., Maxwell S.R.J., Thorpe G.H.G. An investigation of the antioxidant activity of black tea using enhanced chemiluminescence. Free Rad. Res., 26, 291, 1997.
23. Merényi G., Lind J., Eriksen T.E. Luminol chemiluminescence chemistry, excitation, emitter. J. Biolumin. Chemilumin., 5, 53, 1990.
24. Eriksen T.E., Lind J., Merényi G. Oxidation of luminol by chlorine dioxide: Formation of 5-amino-phthalazine-1,4-diene. J. Chem. Soc. Faraday Trans., 77, 2125, 1981.
25. Brestel E.P. Co-oxidation of luminol by hypochlorite and hydrogen peroxide. Implications for neutrophil chemiluminescence. Biochem. Biophys. Res. Commun., 126, 482, 1985.
26. Arnhold J., Mueller S., Arnold K., et al. Mechanisms of inhibition of chemiluminescence in the oxidation of luminol by sodium hypochlorite. J. Biolumin. Chemilumin., 6, 307, 1993.
27. Bellinati-Pires R., Melki S.E., Colletto G.M.D.D., Carneiro-Sampaio M.M.S. Evaluation of a fluorochrome assay for assessing the bactericidal activity of neutrophils in human phagocyte dysfunctions J. Immunol. Methods, 119, 189, 1989.
28. Hed J. The extinction of fluorescence by crystal violet and its use to differentiate between attached and ingested microorganisms in phagocytosis. FEMS Microbiol. Lett., 1, 357, 1977.
29. Goldner M., Farkas-Hirnsley H., Kormendy A., Skinner M. Bacterial phagocytosis monitored by fluorescence and extracellular quenching: Ingestion and intracellular killing. Lab. Med., 14, 291, 1983.
30. Barnes P.J. Peactive oxygen species in asthma. Eur. Respir. Rev., 10, 240, 2000.
31. Cromwell O., Hamid Q., Corrigan C., Barkans J., Meng Q., Collins P. Expression and generation of interleukin-8, IL-6 and granulocyte-macrophage colony-stimulating factor by bronchial epithelial cells and enhancement by IL-1 beta and tumor necrosis factor-alpha. Immunology, 77, 330, 1992.
32. Adler K., Fisher B., Wright D., Cohn L., Becker S. Interaction between respiratory epithelial cells and cytokines: Relationship to lung inflammation. Ann. N.Y. Acad. Sci., 725, 128, 1994.
33. 4-induced bronchoconstriction in patients with asthma. Am. J. Resp. Crit. Care Med. Abs., 151, 378, 1995.
34. Taylor I.K., O'Shaughness K.M., Fuller R.W., et al. Effect of cysteinyl-leukotriene receptor antagonist ICI 204, 219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects. Lancet, 337, 690, 1991.
35. 4 receptor antagonist, in subjects with bronchial asthma. Am. J. Respir. Crit. Care Med., 150, 618, 1994
36. Baud L., Goldman D.W., Koo C.H., Marotti T., Harvey J.P., Goetzl E.J. Molecular and cellular diversity of the polymorphonuclear leukocyte receptors for leukotrienes In: Samuelsson B., Paoletti R., Ramwell P.W. (Eds.). "Advances in Prostaglandins, Thromboxane and Leukotriene Research". Vol. 17, Raven Press, New York, 1987, pp. 163.
37. 4 to a receptor on human polymorphonuclear leukocytes. J. Exp. Med., 157, 628, 1983.
38. 4 binding to human neutrophils. Prostaglandins, 28, 837, 1984.
39. 4. Immunology, 62, 53, 1987.
40. 4, histamine and bradykinin on cytostatic calcium concentrations and adhesiveness of endothelial cells and neutrophils. Clin. Exp. Immunol., 103, 454, 1996.
41. 4-stimulated secretion in human neutrophils. Comparison with the chemotactic peptide formyl-methionyl-leucyl-phenylalanine. Eur. J. Biochem., 162, 161, 1987.
42. 4 receptor antagonist, SR 2640, and possible relation to modulation of chemotaxis. Agents & Actions, 29, 299, 1990.
43. 4 receptors on guinea-pig alveolar macrophages. Prostaglandins, 35, 747, 1988.
44. Kantar A., Oggiano N., Giorgi P.L., et al. Effect of nedocromil sodium on polymorphonuclear leukocyte plasma membrane. Mediat. Inflamm., 3 (Suppl. 1), S21, 1994.
45. Berridge M.J. Inositol triphosphate and diacylglycerol as a second messenger. Biochem. J., 220, 345, 1980.
46. Gelas P., Von Tscharner V, Record M., Baggiolini M., Chap H. Human neutrophil phospholipase D activation by N-formyl-methionyl-leucyl-phenylalanine reveals a two step process for the control of phosphatidylcholine breakdown and oxidative burst. Biochem. J., 287, 67, 1992.
47. Jeasitis A.J., Allen R.A. Activation of the neutrophil respiratory burst by chemoattractants: Regulation of the N-formyl peptide receptor in the plasma membrane. J. Bioenerg. Biomemb., 20, 679, 1988.
48. Showell H.J., Freer R.J, Zigmond S.H., et al. The structure-activity relations of synthetic peptides as chemotactic factors and inducers of lysosomal secretion for neutrophils J. Exp. Med., 143, 1154, 1976.
49. Nowak D., Krol M., Bialasiewicz P. Effect of serine proteinase inhibitors on intracellular free calcium rise in human polymorphonuclear leukocytes after stimulation with receptor agonists. Arch. Immunol. Ther. Exp., 46, 121, 1998.
50. Robinson J.M., Badwey J.A. The NADPH oxidase complex of phagocytic leukocytes. A biochemical and cytochemical view. Histochemistry, 103, 163, 1995.
51. Lehmeyer J.E., Snyderman R., Johnson R.B. Jr. Stimulation of neutrophil oxidative metabolism by chemotactic peptides: Influence of calcium ion concentration and cytochalasin B in comparison with stimulation by phorbol myristate acetate. Blood., 54, 35, 1979.
52. Raulf M., König W. Modulation of leukotriene release from human polymorphonuclear leukocytes by PMA and arachidonic acid. Immunology, 64, 51, 1988.
53. Raulf M., Stüning M., König W. Metabolism of leukotrienes by L-gamma-glutamyl-transpeptidase and dipeptidase from human polymorphonuclear granulocytes. Immunology, 35, 135, 1985.
54. Wright D.C., Kennedy J.A., Kuipers P.J., Ferin M.A. Stimulus-dependent effects of CI-986 on arachidonic acid metabolism by human neutrophils. Inflamm. Res., 44, 74, 1995.